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The lungs are generated by branching morphogenesis as a result of reciprocal signalling interactions
between the epithelium and mesenchyme during development. Mutations that disrupt formation of either
the correct number or shape of epithelial branches affect lung function. This, in turn, can lead to congenital
abnormalities such as cystadenomatoid malformations, pulmonary hypertension or lung hypoplasia. Defects
in lung architecture are also associated with adult lung disease, particularly in cases of idiopathic lung fibro-
sis. Identifying the signalling pathways which drive epithelial tube formation will likely shed light on both
congenital and adult lung disease. Here we show that mutations in the planar cell polarity (PCP) genes
Celsr1 and Vangl2 lead to disrupted lung development and defects in lung architecture. Lungs from
Celsr1Crsh and Vangl2 Lp mouse mutants are small and misshapen with fewer branches, and by late gestation
exhibit thickened interstitial mesenchyme and defective saccular formation. We observe a recapitulation of
these branching defects following inhibition of Rho kinase, an important downstream effector of the PCP sig-
nalling pathway. Moreover, epithelial integrity is disrupted, cytoskeletal remodelling perturbed and mutant
endoderm does not branch normally in response to the chemoattractant FGF10. We further show that
Celsr1 and Vangl2 proteins are present in restricted spatial domains within lung epithelium. Our data
show that the PCP genes Celsr1 and Vangl2 are required for foetal lung development thereby revealing a
novel signalling pathway critical for this process that will enhance our understanding of congenital and
adult lung diseases and may in future lead to novel therapeutic strategies.
INTRODUCTION
Lung diseases, both congenital and late onset, represent a sig-
nificant clinical burden, and current treatments available are
often limited and only partially effective. Defects in lung devel-
opment result in a range of human disorders including: cystade-
nomatoid malformations, pulmonary hypertension and agenesis
or hypoplasia of the lung (1–3). Importantly, efficient post-natal
lung function requires the generation of normal cell and tissue
architecture in utero (3). In adult lung diseases such as idio-
pathic pulmonary fibrosis and adult respiratory distress syn-
drome one of the dominant features is fibrosis (4); which
results in abnormal tissue structure leading to impaired gas/air
exchange and respiratory dysfunction.
Development of the lung and other branched organs, is
driven by signalling between the mesenchyme and epithelium
which directs the growth and patterning of buds. Through the
study of mouse mutants, a number of these signals that
coordinate branching morphogenesis have been identified
including members of the FGF, BMP and Wnt growth factor
families (5–8). Moreover, complex morphogenetic move-
ments are required to form and precisely shape the networks
of three-dimensional (3D) epithelial tubes within the lung
and this is achieved through modification of both the
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Figure 1. Disruption of Celsr1 or Vangl2 causes lung morphogenesis defects. Analysis of E18.5 separated mouse embryonic lung lobes (A–C) reveals visibly
misshapen lung lobes of Celsr1Crsh (B) and Vangl2Lp (C) lungs compared with wild-type (A). H&E staining of sections of E14.5 Celsr1Crsh (E) and Vangl2Lp (F)
lungs compared with wild-type (D). (P) There was a significant reduction in the number of epithelial branches in both mutants at E14.5: wild-type 44.42, +2.43,
n ¼ 12; Celsr1Crsh 20.00, +1.3, n ¼ 12; Vangl2Lp 18.58, +1.48, n¼12. H&E sections from a minimum of three mutants for each genotype were used for
counts. Airway lumina were narrow or absent in many Crsh/Crsh and Lp/Lp airways and epithelium had a multilayered morphology, in contrast to the
wider lumina surrounded by single layered epithelium that predominates in wild-type. H&E staining of sections of E18.5 wild-type (G), Celsr1Crsh (H),
Vangl2Lp (I) lungs. Control lung sections display typical saccular structure and evidence of septation (arrows in G). In contrast, mutant lung sections (H, I)
show no evidence of septation. Number (Q) and width (R) of airways is dramatically reduced at E18.5. Number or width of airways was determined by counting
airways visible in a complete section of E18.5 lungs from a minimum of two separate embryos (Q) wild-type 90.89, +3.97; Celsr1Crsh 52.22, +3.37; Vangl2Lp
69.11, +3.43, n ¼ 9 for each genotype (R) wild-type 12.13, +0.05, Celsr1Crsh 4.21, +0.03, Vangl2Lp 4.63, +0.03, n ¼ 10 for each genotype. E14.5 cryosec-
tions immunostained for expression of pan-cytokeratin (J–L, inserts show airways at higher magnification), corresponding sections to (J–L) counterstained with
DAPI (M–O), dashed lines outline cytokeratin positive cells (as seen in J–L) difficult to distinguish from surrounding cells in Celsr1Crsh (N) and Vangl2Lp (O),
airways are easily visualized in wild-type (M). Scale bars: (A–C) 62.5 mM; (D–F) 50 mM; (G–O) 12.5 mM, inserts in (D–F); (J–L) 5 mM; ∗P , 0.05.
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intracellular cytoskeletal network and intercellular interactions
like cell adhesion. However, the signalling pathways directing
organization of the cytoskeleton during lung development are
not well known. Cytoskeletal remodelling can be mediated by
RhoGTPases and Rho kinases and previous studies have
shown that Rho kinase inhibition causes a severe reduction
of lung branching morphogenesis (9,10). Rho kinase is a
downstream effector of a number of signalling pathways
including the planar cell polarity (PCP) pathway (11–15),
which itself is capable of controlling the organized re-structuring
of epithelial tissue during development. Understanding the
relationship between the PCP pathway and lung development
has been recently highlighted as a key unresolved question in
pulmonary biology (16).
The PCP pathway is perhaps best known for directing polar-
ization of cells orthogonal to the axis of apical–basal polarity
within the plane of an epithelium. In addition to regulating pat-
terning of external epidermal structures such as wing hair cells
in Drosophila (17), the PCP pathway is more widely utilized for
modifying cellular direction and movement (18–21). The end
result of the pathway is polarization of the cytoskeleton
which, in turn drives cellular morphogenesis and/or morphogen-
etic movement such as convergent extension. Recent studies
show that this pathway can also mediate directed movement
of groups of cells and is required for female reproductive
tract development and kidney tubule formation (22–24). We
hypothesized that the cellular arrangements necessary for lung
epithelial tube formation could be coordinated, in part, by the
PCP signalling pathway to regulate tissue morphogenesis. Pre-
vious studies have shown that Celsr1 and Vangl2 are key com-
ponents of the mammalian PCP signalling pathway (20,21,25).
Moreover, mouse mutants of both these genes show extensive
phenotypic similarities such as craniorachischisis and disrupted
orientation of stereocilia in the cochlea (20,21). We therefore
sought to determine whether this signalling pathway is required
for lung epithelial tube formation using the previously identified
mouse mutants Celsr1Crsh and Vangl2Lp.
In summary, our manuscript reports the novel finding that
mutations in the PCP-related genes Celsr1 and Vangl2 result
in smaller lungs with a reduced number of epithelial branches,
disordered cellular arrangements and, frequently, narrow or
absent lumina. This lung phenotype is characterized by disrup-
tion of the actin-myosin cytoskeleton in both Celsr1Crsh and
Vangl2Lp and we identify an additional role for Celsr1 in
bud bifurcation. We therefore propose that the PCP signalling
pathway is required for normal lung branching morphogenesis
and that disruption of this pathway leads to defective tissue
morphogenesis likely caused by cytoskeletal defects.
RESULTS
Lung morphogenesis is disrupted in Celsr1Crsh
and Vangl2Lp mutants
We examined lungs taken from two mouse mutants which
carry loss of function mutations affecting the following
proteins: Celsr1 (crash, Crsh) and Vangl2 (loop-tail, Lp)
(26–30). Briefly, we observed smaller, misshapen lobes and
fewer airways with narrow or absent lumina in both Celsr1Crsh
and Vangl2Lp mutants.
Specifically, macroscopic analysis of Celsr1Crsh and
Vangl2Lp homozygotes revealed that mutant lungs were
smaller than wild-type littermates, most strikingly, the top-
ology of the lungs was often highly disturbed suggesting
that in the absence of Celsr1 and Vangl2, the lung lobes
were not able to attain their normal shape (Fig. 1A–C). Analy-
sis of sections of E14.5 Celsr1Crsh and Vangl2Lp homozygous
mutant lung stained with H&E (Fig. 1E and F) revealed
changes to the structure of the epithelium from that observed
in wild-type lung (Fig. 1D). During normal lung development,
airway lumina are initially very narrow and are surrounded by
multilayered/pseudostratified type epithelium. As develop-
ment proceeds, the lumina widen and epithelial thickness
subsequently decreases. In wild-type lung sections at E14.5,
most airways contained clearly visible lumina surrounded by
a single layer of uniformly aligned columnar epithelium
(Fig. 1D and insert). However, in both Celsr1Crsh and
Vangl2Lp homozygous lungs the majority of lumina were con-
siderably narrower and the luminal space often contained cells
(Fig. 1E, F and inserts). In addition, the surrounding epithelial
cells were frequently multilayered and/or disorganized and not
aligned uniformly. Although the phenotypes were broadly
similar in both mutants, it was notable that Celsr1Crsh
airways were frequently narrower and cells appeared more
densely packed than those in Vangl2Lp.
At E18.5 hypoplasia was evident in mutant lungs (Fig. 1H
and I) compared with wild-type (Fig. 1G). Moreover, lungs
appeared to lack septation and had thickened interstitial
mesenchyme. Quantification of these mutant lungs revealed
significantly reduced numbers of airways compared with wild-
type at E14.5 and E18.5 (Fig. 1P and Q) as well as decreased
width of airways (Fig. 1R).
To further highlight the disordered cellular arrangements in the
mutant lungs, we immunostained E14.5 lung sections using a
pan-cytokeratin antibody to mark epithelial cells and DAPI to
highlight all cell nuclei. Wild-type epithelial cells were readily
distinguishable from mesenchyme by both cytokeratin and
DAPI labelling. The majority of wild-type airways consisted of
an open lumen surrounded by a single layer of uniformly
aligned nuclei (Fig. 1J and M). In contrast in both mutants, the
epithelial cells appeared highly disorganized and randomly
orientated (Fig. 1K, L, N, O) with either small or no lumina
(see inserts in Fig. 1K and L compared with J). It was often not
possible to distinguish epithelial airways from surrounding
mesenchyme by DAPI labelling. Celsr1Crsh airways appeared
more severely affected than Vangl2Lp.
Cell differentiation, proliferation and apoptosis are
not affected in Celsr1Crsh and Vangl2Lp lungs
To begin to determine the cause of the lung tissue defects in
Celsr1Crsh and Vangl2Lp mutants we first looked for evidence
of changes in cell differentiation, proliferation and apoptosis.
To determine whether epithelial cell differentiation was
affected in the mutants, we performed immunohistochemistry
on E18.5 Crsh/Crsh (Fig. 2B and E) and Lp/Lp (Fig. 2C and F)
mutant lungs using a-smooth muscle actin, to highlight
smooth muscle cells surrounding proximal airways, and pro-
surfactant protein C, a marker of alveolar type II cells in
distal airways. We found no major changes in expression of
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these markers compared with wild-type littermates (Fig. 2A
and D). However, the disrupted tissue architecture in
Celsr1Crsh and Vangl2Lp made detailed comparison of
Pro-SpC staining in wild-type and mutant lungs difficult. To
circumvent this issue, we compared the percentage of
Pro-SpC positive cells in wild-type, Celsr1Crsh and Vangl2Lp
lungs at E18.5 and no significant difference was observed
(Fig. 2G). Comparison of a further two cell type specific
markers (CC-10 for Clara cells and Aquaporin-5 for alveolar
type I cells) also showed no obvious difference between wild-
type and mutants (data not shown). We then compared the per-
centage of proliferating cells in E14.5 wild-type and mutant
lung sections to determine whether the reduced number of
airways was due to lack of tissue growth. Importantly, there
was a comparable percentage of proliferating cells in wild-
type, Celsr1Crsh and Vangl2Lp (Supplementary Material,
Fig. S1A–C and H). Similarly, no change in the level of
apoptosis was observed in Celsr1Crsh or Vangl2Lp homozy-
gous lungs (Supplementary Material, Fig. S1D–F). We also
saw no changes in proliferation or apoptosis in either mutant
at E11.5 when mutants are morphologically indistinct from
wild-type (Supplementary Material, Fig. S1G and I). The
absence of changes in cell differentiation, proliferation or
apoptosis suggests that the cellular disorganization observed
in Celsr1Crsh and Vangl2Lp mutants is caused by impaired
cell and tissue morphogenesis. Taking this data into account,
we hypothesize that the smaller size of mutant lungs is due
to the reduced width and number of lumina and increased
compaction of the tissue.
Branching morphogenesis defects in Celsr1Crsh
and Vangl2Lp ex vivo lung culture
The predominant driver of lung morphogenesis prior to E16.5
is branching morphogenesis, the process whereby the simple
epithelial tube splits into numerous smaller tubes to form the
vast number of airways. As airway number is significantly
reduced at E14.5 in the mutant lungs, we hypothesized that
PCP function is required for lung bud branching. Homozygous
Celsr1Crsh and Vangl2Lp mutant embryos do not exhibit devel-
opmental delay as assessed by limb development, however,
the rostrocaudal axis is markedly shorter due to disruption of
axial convergent extension (31,32). The shortened axis likely
results in reduced intrathoracic space, which can affect lung
development (33). To circumvent space restriction, we used
ex vivo culture of E11.5 lungs from intercrosses between
Celsr1Crsh or Vangl2Lp heterozygotes and examined homozy-
gous mutant and wild-type lungs at 0 and 48 h. Bud number in
wild-type and mutant lungs was the same at the beginning of
branching morphogenesis, t ¼ 0 (Fig. 3A–C). However, after
Figure 2. Immunohistochemical analysis of lung epithelial cell differentiation in Celsr1Crsh and Vangl2Lp compared with wild-type. Comparison of E18.5
control lung sections (A, D) with Celsr1Crsh (B, E), and Vangl2Lp (C, F) showed no apparent alteration in the expression of proximal airway marker, alpha
smooth muscle actin (A–C) or distal airway marker, pro-surfactant C (D–F) Graphical comparison of the percentage of Pro-SP-C positive cells in wild-type
and mutant lungs (G) confirmed no significant difference between control and Celsr1Crsh or Vangl2Lp lungs, n ¼ 8 for each genotype. Counts were performed
on sections of left lung lobe obtained from three mutants for each genotype, n ¼ 8 for each genotype. Wild-type 45.12%, +3.00; Celsr1Crsh 42.60%, +3.72;
Vangl2Lp 44.93%, +1.43. Scale bars: (A–F) 12.5 mM.
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48 h in culture the mutant lungs were smaller with signifi-
cantly fewer terminal buds than wild-type littermates resulting
in a simpler epithelial tree structure (Fig. 3D–F and G). More-
over, terminal buds were significantly enlarged (dashed lines
in Fig. 3E and F compared with Fig. 3D, quantification in
Fig. 3H). These results indicate that Celsr1 and Vangl2 are
required for normal lung branching morphogenesis and dis-
rupted branching in mutant lungs is not a consequence of
space restriction.
Celsr1 and Vangl2 are required for all three modes
of lung branching
Recent studies identified three modes of branching in mouse
lung: domain branching, planar bifurcation and orthogonal
bifurcation (34). These three modes of branching are used
repeatedly to form a stereotypical pattern of branches in the
lung. Domain branching is particularly used during the early
stages of branching and involves new bud formation at
regular intervals both along the length and around the circum-
ference of an existing branch creating a ‘bottle-brush’ type of
structure. Planar and orthogonal bifurcation both involve a
single bud tip separating into two distinct tips that are either
within the same plane (planar) or at right angles (orthogonal)
to the original end bud (see Metzger et al. 34 for further
details). To determine whether mutations in the PCP
pathway affected all branching modes or whether PCP signal-
ling is part of the molecular mechanisms controlling formation
of branches by one particular mode, we immunostained wild-
type E12.5 and E14.5 whole lungs with antibodies to Celsr1 or
Vangl2 and counterstained with pan-cytokeratin to highlight
epithelium (Fig. 4, yellow, red, white lines denote planar,
domain and orthogonal branching, respectively). Laser scan-
ning confocal examination of wild-type lungs revealed
Celsr1 and Vangl2 expression in all three branch modes
(Fig. 4B, E, F and H). In addition, despite the defects
already described and in particular the decreased branch
number, examples of all three modes of branching were
visible in Celsr1Crsh and Vangl2Lp homozygous lungs
(Fig. 4C, D and data not shown) providing further evidence
that Celsr1 and Vangl2 are part of a general mechanism gov-
erning bud/branch formation.
Celsr1Crsh and Vangl2Lp mutant lungs phenocopy lungs
treated with Rho kinase inhibitor and Rho activation
partially rescues the branching defect in Crsh
Rho kinases are key downstream effectors of the PCP
pathway. Previous studies have shown that Rho kinases are
important mediators of cellular morphogenesis; they facilitate
cytoskeletal remodelling, play an obligatory role in embryonic
morphogenesis and are required for normal lung branching
morphogenesis (10,35,36). To investigate whether Rho
kinase may be part of the downstream signalling pathway uti-
lized by Celsr1 and Vangl2 in lung development, we explanted
lungs from wild-type mice and cultured them with Rho kinase
inhibitor (Y27632) (32,37). We observed a dose-dependent
inhibition of branching morphogenesis and enlarged terminal
buds (Fig. 3I and L) as reported previously (9). Importantly
the phenotype following Rho kinase inhibition is very
similar to the phenotype of Celsr1Crsh and Vangl2Lp lungs
both in culture and in vivo. Moreover, common to both
mutants and wild-type lungs treated with Y27632, direct dis-
ruption of the actin cytoskeleton with Cytochalasin D also
resulted in fewer and broader buds (Fig. 3J and M). Neither
Y27632 nor Cytochalasin D adversely affected cell survival,
as assessed by comparing the number of fragmented nuclei
in control and treated explants following DAPI staining of
explants post-culture (Supplementary Material, Fig. S2A–C).
Notably, addition of the Rho activator CNF-1 (38) to wild-
type lung explants stimulated branching morphogenesis,
resulting in an increased number of buds (Fig. 3N).
In a separate set of experiments, the addition of CNF-1 to
Crsh/Crsh mutant lungs also led to an increase in bud
numbers (Fig. 3K and N). The increase in bud numbers was
greater in Crsh/Crsh lungs than in wild-type (24% increase
in Crsh/Crsh compared with 16% increase in wild-type
Fig. 3N) indicating that activating the Rho signalling
pathway in mutant embryos is able to partially ameliorate
the branching defect. These data are consistent with Rho
kinase being a downstream effector of the PCP signalling
pathway in lung development. Thus, we propose that the
defective cellular organization in Celsr1Crsh and Vangl2Lp
mutants results from disruption to Rho kinase function
which likely leads to cytoskeletal defects, thus perturbing
tissue structure.
Mutations in Celsr1 and Vangl2 lead to disrupted
cytoskeletal organization and disordered epithelial airways
To further investigate the hypothesis that Celsr1 and Vangl2
may influence tissue morphogenesis by affecting cytoskeletal
organization, we analyzed the appearance of the actin-myosin
cytoskeleton and adherens junctions in E14.5 lung tissue.
Phalloidin staining of F-actin highlighted the disorder
amongst cells in mutant tissue. In wild-type tissue, staining
was visible around the entire circumference of cells, this
was particularly evident in mesenchyme; in epithelial
airways, a strong band of actin was visible surrounding the
lumen (Fig. 5A). However, in Celsr1Crsh and Vangl2Lp lung
tissue, actin was more discontinuous and diffuse around the
circumference of many cells and we did not observe a distinct
band of actin surrounding the narrower mutant lumina
(Fig. 5B and C). At E18.5, phalloidin staining continued to
reveal differences in the F-actin cytoskeleton of wild-type
and mutant lung tissue. In wild-type lung, areas of focal
enrichment of actin were observed within individual cells
throughout the tissue, particularly in cells adjacent to
airways (Fig. 5D). In both mutants, localized enrichment of
actin was observed in some cells, however, this was either dis-
tributed evenly around the entire circumference of cells in
Celsr1Crsh (Fig. 5E) or was discontinuous and diffuse in
Vangl2Lp (Fig. 5F). Moreover, in both mutants, those cells
which did display focal enrichment of actin were frequently
not adjacent to ‘airways’. Levels of non-muscle myosin II,
another critical component of the cytoskeleton which directly
links the Rho signalling pathway with cytoskeletal dynamics
(39), were also perturbed and its spatial distribution altered
at E14.5 in Celsr1Crsh and Vangl2Lp mutants (Fig. 5H and I;
wild-type in G). In common with our earlier observations,
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both F-actin and myosin appeared considerably more dis-
rupted in Celsr1Crsh than in Vangl2Lp. The cytoskeletal
defects observed in Celsr1Crsh and Vangl2Lp lungs might be
expected to cause disruption of adherens junctions, however,
staining with anti-b-catenin antibody (Fig. 5J–L) showed no
apparent changes in Celsr1Crsh or Vangl2Lp lungs indicating
that adherens junctions were not grossly affected.
In light of the aberrant epithelial tube morphogenesis in
Celsr1Crsh and Vangl2Lp lungs, it was important to determine
whether apical–basal polarity was disrupted. Immunolabelling
with ZO-2 and laminin, to highlight the apical and basal sides
of airways, respectively (Fig. 5M–O), as well as with the
apical membrane marker aPKCz (Fig. 5P–R) and GM-130
(Supplementary Material, Fig. S3A–C) to mark the polarized
localization of the Golgi apparatus, showed no overt disrup-
tion to apical–basal polarity in either mutant. Some differ-
ences in the precise patterns of expression of markers was
visible in mutants, however, this likely reflects the misalign-
ment of cells, the narrowed lumina and the overall pertur-
bation of tissue morphogenesis, rather than disrupted
apical–basal polarity. Thus, mutations in Celsr1 and Vangl2
lead to disruption of the cytoskeleton resulting in disordered
epithelial airways.
Lung endoderm from Celsr1Crsh and Vangl2Lp mutants
responds to the chemoattractant FGF10 but is unable
to branch
We wished to determine whether the tissue morphogenesis
defects observed in Celsr1 and Vangl2 mutant lungs could
reflect a defect in the response of mutant endoderm to a key
signal for branching. To test this idea we exposed Celsr1Crsh,
Vangl2Lp and wild-type lung epithelium denuded of mesench-
yme to FGF10, which normally signals from the mesenchyme
to direct lung branching. Both wild-type and mutant lungs
responded to the FGF10 stimulus in terms of growth.
However, whereas wild-type epithelium formed multiple
long and narrow buds (Fig. 6A and B), in most cases, the
mutant lung epithelium did not undergo any branching in
response to FGF10 (Fig. 6C, D or rarely one or two short
stumpy buds formed). Staining for phospho-ERK1/2, which
is up-regulated in response to FGF10 in the lung (40), revealed
no significant difference in the number of positive cells in
wild-type and mutant lung epithelium and this was confirmed
by western blot (Fig. 6E and F). Together these results indicate
that the FGF signalling pathway, at least that mediated by
ERK1/2 activators, is unaffected in mutant lungs. Thus,
normal morphogenetic movement within the epithelium is
affected upon disruption of the PCP genes Celsr1 and
Vangl2, rendering the epithelium almost incapable of branch-
ing in response to an FGF10 stimulus.
Celsr1 and Vangl2 proteins are spatially restricted
and differentially expressed in lung epithelia
To provide additional mechanistic insight into how Celsr1 and
Vangl2 proteins regulate tissue morphogenesis during lung
branching, we next examined their expression patterns in
E11.5 and E14.5 lung sections by immunohistochemistry.
Studies in other tissues and organisms have shown that these
proteins often co-localize at cell membranes and are thought
to form a multi-protein complex (20,41). In the lung we did
observe co-localization in some regions of lung epithelia but
we also noted some differences in the spatial expression of
Celsr1 and Vangl2.
At E11.5 at the onset of branching of the secondary buds,
Celsr1 expression was mainly restricted to lung epithelium and
staining was enriched in the basal membranes as well as
towards the more apical side of airways (Fig. 7A). Double immu-
nostaining of Celsr1 with laminin revealed co-localization indi-
cating that Celsr1 was also present in the basement membrane
(Fig. 8A–C). This surprising result was confirmed by comparison
of the Celsr1 and laminin double labelling with that for laminin
and the basolateral membrane marker, b-catenin; no
co-localization of b-catenin and laminin was observed since
these two proteins are expressed in different compartments
(compare Supplementary Material, Fig. S3D–F with H–J). We
also noted that basement membrane Celsr1 staining frequently
was not evenly distributed around the entire airway and instead
was localized to the basement membrane on one side or a
portion of the airway, rather than being evenly distributed
around it. Interestingly, laminin shares this uneven, differential
distribution around the basal side of airways which results from
thinning or discontinuity of the basement membrane at the
epithelial/mesenchymal interface in regions of active bud out-
growth (42). The co-localization of Celsr1 with laminin in the
basement membrane indicated that Celsr1 associates with areas
of morphogenetic stability such as clefts (42).
Figure 3. Ex vivo lung cultures reveal that mutations in Celsr1 and Vangl2 phenocopy treatment with Rho kinase inhibitor and Rho kinase activation partially
rescues the branching defect in Celsr1Crsh. E11.5 left lung lobes from wild-type (A, D); Vangl2Lp (B, E) and Celsr1Crsh (C, F) were cultured for 48 h. t ¼ 0
mutant lungs (B, C) were indistinguishable from wild-type lungs (A). t ¼ 48h wild-type lungs exhibit increased number of terminal buds (D, G). A smaller
increase in terminal buds is observed in Vangl2Lp (E, G) and Celsr1Crsh (F, G) explants: wild-type 9.67, +0.33, n ¼ 14; Crsh 6.43, +0.48, n ¼ 8; Lp 4.75,
+0.2, n ¼ 6. Mutant lung buds are also expanded (E, F, H) relative to wild-type (D, H): wild-type 67.47, +4.54, n ¼ 10; Crsh 81.85, +4.34, n ¼ 16, Lp
96.5, +10.6, n ¼ 8. Addition of Y27632 severely inhibits branching morphogenesis of a wild-type lung in a dose dependent manner (I, L): lung control
13.14, +0.51, n ¼ 7; lung 10 mM Y27632 5.60, +0.51, n ¼ 5; lung 30 mM Y27632 4.33, +0.42, n ¼ 6. Disruption of the cytoskeleton with 100 ng/ml Cyto-
chalasin D also inhibits lung branching morphogenesis (J, M): wild-type 12.33, +0.97, n ¼ 27; CytoD 5.28, +0.32, n ¼ 18. Explants in (I) and (J) have broad
branches and appear similar to those from Vangl2Lp (E) and Celsr1Crsh (F). Wild-type lung explants treated with 20 ng/ml CNF-1 show a small increase in
number of epithelial buds formed (N): wild-type (untreated) 7, +0.94, n ¼ 6; wild-type with CNF-1 8.33, +1.13, n ¼ 9, two-tailed P-value ¼ 0.4819. This
result was consistent though not statistically significant. Whereas in a separate set of experiments, treatment of Crsh homozygous lung explants with 20 ng/
ml CNF-1 results in a greater, statistically significant increase in bud numbers (K, N): Crsh (untreated) 6.25, +0.52, n ¼ 8; Crsh with CNF-1 8.18, +0.63,
n ¼ 11. Explants were stage matched at t ¼ 0 to allow direct comparison of the number of end buds between control and treated or wild-type and mutant
lungs within each experiment. Scale bars: (A–F, I–K) 63 mM. ∗P , 0.05.
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Figure 4. Celsr1 and Vangl2 are expressed in all modes of branching. Confocal images of wild-type E14.5 (A, B, G, H) and Celsr1Crsh (C, D) or E12.5 wild-type
(E, F) whole lungs immunostained with anti-cytokeratin (A, C, D, G), anti-Celsr1 (B, E, F) or anti-Vangl2 (H) antibodies. Pictures are slices showing a single
layer from a z-stack. In wild-type lungs Celsr1 and Vangl2 are expressed in all three branching modes as described by Metzger et al. (34); examples of planar
branching (yellow lines in A, C, D, G); domain branching (red lines in A, D, G) and orthogonal branching (white lines in A, C, G) are highlighted. All three
modes are present in Celsr1Crsh and Vangl2Lp lungs (C, D and data not shown) indicating the defects in Celsr1 and Vangl2 are not restricted to a specific mode of
branching. Scale bars: (A, B) 125 mM plus ×1.2 zoom, (C) 125 mM plus ×1.2 zoom, (D) 125 mM plus ×1.7 zoom. (E, F) 125 mM plus ×6.3 zoom, (G, H)
125 mM plus ×1.7 zoom.
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Figure 5. Mutant lungs display aberrant cell architecture, yet apical–basal polarity remains intact. Cryosections of E14.5 wild-type (A, D, G, J, M, P) Celsr1Crsh (B,
E, H, K, N, Q) and Vangl2Lp (C, F, I, L, O, R). Rhodamine phalloidin staining of F-actin reveals cytoskeletal defects in mutants at E14.5 (B, C) and E18.5 (E, F)
compared with wild-type (A, D), as does staining with antibodies to non-muscle myosin IIA in mutants (H, I), compared with wild-type (G). Anti-b-catenin staining
appears normal in Celsr1Crsh (K) and Vangl2Lp (L), compared with wild-type (J). Normal apical–basal polarity is revealed in lung by double-labelling of wild-type
(M), Celsr1Crsh (N) and Vangl2Lp (O) airways with ZO-2 (red) and laminin (green in M–O and red in P–R) and by double-labelling of wild-type (P) Celsr1Crsh (Q)
and Vangl2Lp (R) with aPKCz (green). Scale bars: (A–F) 5 mM, (G–L) 5 mM, (G–L) 25 mM, (M–R) 12.5 mM plus 3× zoom.
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Punctate Vangl2 staining was observed in both epithelium
and mesenchyme, though expression in the epithelium was
stronger. In the epithelium, Vangl2 staining was more
evenly distributed around cell membranes than Celsr1,
however, in many airways, we observed an enrichment of
Vangl2 expression in cells surrounding the lumen (Fig. 7B),
in agreement with a previous study (43).
At E14.5 the patterns of Celsr1 (Fig. 7C) and Vangl2
(Fig. 7E) were similar to E11.5, but the enrichment of
Celsr1 towards the luminal side of airways was more predomi-
nant. Immunostaining of E14.5 lung sections from homozy-
gous mutants of Celsr1Crsh with anti-Celsr1 (Fig. 7D) and
Vangl2Lp with anti-Vangl2 (Fig. 7F) antibodies revealed a dra-
matic reduction in protein levels in mutant lung tissue relative
to wild-type. This demonstrates the specificity of the anti-
bodies and provides supportive evidence that these mutations
represent loss of function alleles.
The spatial and temporal distribution of Celsr1 and Vangl2
in lung epithelium clearly overlaps in some regions, such as
the apical membranes, but also differs in others, suggesting
a differential role for these proteins in some aspects of lung
development. This observation prompted us to examine
whether Celsr1 was correctly localized in Vangl2Lp mutants
and conversely whether Vangl2 was correctly localized in
Figure 6. Mutant lung endoderm responds to FGF10 but is unable to undergo branching. (A, B) Wild-type lung endoderm branches in response to 400 ng/ml
FGF10 (mean bud number ¼ 11, n ¼ 6). (C, D) mutant lungs do not branch in response to FGF10 (mean bud number Crsh ¼ 0.9, n ¼ 6). P-ERK1/2 staining of
E14.5 lung, shows no significant difference in percentage of P-ERK1/2 positive cells in the epithelium of mutants compared with wild-type controls (E): wild-
type 55.17%, +3, n ¼ 10; Crsh 51.97%, +6.3, n ¼ 7, P ¼ 0.6074; Lp 56.45%, +3.9, n ¼ 9, P ¼ 0.7939. Data from three embryos for each genotype. Western
blotting reveals no change in the relative levels of P-ERK1/2 in wild-type and Lp/Lp or Crsh/Crsh littermates (F). Scale bars: (A–D) 5 mM.
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Figure 7. Celsr1 and Vangl2 proteins are spatially restricted and differentially expressed in lung epithelia. (A, B) E11.5 transverse cryosections of lungs immu-
nostained with antibodies against Celsr1 (A) and Vangl2 (B). (C–F) Immunostaining of transverse cryosections of E14.5 wild-type (C, E) with anti-Celsr1 (C)
and anti-Vangl2 (E) antibodies. Corresponding protein levels are dramatically decreased in lung tissue of mutants; anti-Celsr1 in Celsr1Crsh (D) and anti-Vangl2
in Vangl2Lp (F) compared with wild-type (C, E). Immunostaining of Celsr1 protein in Vangl2Lp (G) reveals no change in spatial localization. Enrichment of
Vangl2 protein adjacent to the lumen is lost in Celsr1Crsh (H) mutant lung sections. Scale bars: (A, B) 125 mM plus ×1.9 zoom, (C) 125 mM plus ×2.5
zoom, (D) 125 mM plus ×1 zoom, (E, H) 125 mM plus ×2 zoom, (F, G) 125 mM plus ×3 zoom.
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Celsr1Crsh mutants. In Lp/Lp lungs, the spatial distribution of
Celsr1 did not appear to be altered (Fig. 7G). In contrast, we
observed a loss of enrichment of Vangl2 in cells adjacent to
the lumen in Crsh/Crsh lungs (Fig. 7H) suggesting that
Celsr1 is required for this enrichment of Vangl2. Thus,
despite differences in Celsr1 and Vangl2 expression patterns,
mutations in Celsr1 affect the localization of Vangl2,
suggesting an interaction between these proteins in lung.
Figure 8. Differential expression of Celsr1 and Vangl2 is observed in branching lung endoderm explants and morpholino knockdown highlights a role for Celsr1
in bifurcation. Double-labelling of wild-type E14.5 cryosections with Celsr1 (A, C) and laminin (B, C) antibodies. E11.5 lung endoderm explants cultured for
48 h in 400 ng/ml FGF10 and double labelled with phalloidin (H–K) and Celsr1 (D, E) or Vangl2 (F, G) antibodies. High levels of Celsr1 expression are present
in regions of restricted tissue growth such as points of bifurcation (D, E, H, I). Vangl2 is most highly expressed at the luminal surface of outgrowing buds (F, G, J,
K). E11.5 lung explants from b-actin promoter driven GFP embryos were cultured for 48 h in the presence of control (L–N) or Celsr1 (O–Q) morpholinos and
subsequently imaged over a 24 h period. Images show three timepoints from this series. Scale bars: (A–C) 125 mM ×2 zoom (D, H, F, J) 125 mM ×2.7 zoom,
(E, I) 125 mM ×10 zoom, (G, K) 125 mM ×8 zoom, (L–Q) 50 mM.
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Celsr1 and Vangl2 expression is enriched in highly
specific regions of the branching lung epithelium
Lung branching morphogenesis is a complex 3D process
that depends on interactions between the mesenchyme and
the epithelium. However, it is possible to simplify this
system by culture of the lung endoderm denuded of mesench-
yme in the presence of FGF10 to induce branching. In this
way, we can gain a better 3D view of the spatial expression
of both Celsr1 and Vangl2 in the endoderm during the branch-
ing process. Specifically, wild-type lung endoderm explants
denuded of mesenchyme were cultured with FGF10 to
induce branching and subsequently immunostained for
Celsr1 or Vangl2 and phalloidin to detect F-actin cytoskeleton
(Fig. 8D–K). This 3D view of branching endoderm revealed
dramatic differences in the expression patterns of Celsr1 and
Vangl2. Low levels of both proteins were observed in mem-
branes of epithelial cells, imaging through z-stacks of endo-
derm explants revealed clear enrichment of Vangl2 at the
apical/luminal surface of epithelial buds (Figs 8F, G, J, K
and 4H). Celsr1 was also enriched towards the luminal
surface of buds but in addition, high levels of Celsr1 were
detected in the basement membrane, in regions of restricted
tissue growth, e.g. immediately adjacent to a bud or at sites
of bud bifurcation (Figs 8D, E, H, I and 4E and F) These
data confirm what we had previously observed both in lung
sections (Fig. 7A–C and E) and with wholemount antibody
staining of lungs (Fig. 4B, E, F, H) and strengthen the idea
that the functions of Celsr1 and Vangl2 are not completely
overlapping.
Morpholino knockdown reveals a role for Celsr1
in bud bifurcation
Given the intriguing expression pattern of Celsr1 in the base-
ment membrane surrounding lung endoderm, we sought to
understand more precisely how Celsr1 affects branching mor-
phogenesis. To do this, we conducted time-lapse imaging of
E11.5 wild-type lung explants in the presence of one of two
Celsr1 morpholinos (MO) directed against different Celsr1
sites, or control morpholino. Identical results were obtained
with both Celsr1 MOs. Knockdown efficiency was validated
by immunostaining and western blotting (Supplementary
Material, Fig. S4).
Wild-type lungs cultured with control MO exhibited a
reproducible branching pattern in culture. The process of
branching began with a uniform increase in distal bud size fol-
lowed by bifurcation (Fig. 8L–N). During bifurcation, the two
sides of the bud branched and grew outwards, whereas cells in
the middle were constrained and remained in place. In con-
trast, lungs cultured with Celsr1 MO formed greatly expanded
‘fat’ buds and bifurcation into two new buds did not occur
(Fig. 8O–Q). In Figure 8L and O, a single bud is shown for
both Control and Celsr1-MO at t ¼ 0. In the control, a cleft
forms by 200 min (Fig. 8M) and is in the same position and
deeper by 360 min (Fig. 8N). At t ¼ 0 in in the Celsr1 MO
treated culture (Fig. 8O), a deformity in the epithelial bud is
visible but this is not retained in the same position in the bud
at 200 or 360 min (Fig. 8P and Q). Moreover, the deformity/
apparent cleft does not deepen showing that this is not the
beginning of bifurcation. Considerable movement of the
epithelial sheet occurs in the Celsr1 MO treated explants result-
ing in a looser/uneven bud shape. In some buds, after consider-
able delay, multiple small new buds formed randomly in a
non-stereotypical fashion. The absence of properly co-ordinated
bifurcation of distal lung buds treated with Celsr1 MO coupled
with our protein localization data indicates that Celsr1 is
required for bifurcation during the branching process.
DISCUSSION
Mutations in PCP genes disrupt branching morphogenesis
and cytoskeletal organization
The complex interactions that enable formation of 3D
branched organs are still poorly understood, despite being
essential to an understanding of the pathobiology of many dis-
eases and congenital malfomations. This study demonstrates a
previously undiscovered role for two genes in the PCP
pathway in the control of lung branching morphogenesis.
Our data show that mutations in Celsr1 and Vangl2 disrupt
lung bud branching and cause abnormal epithelial cell
arrangements, cytoskeletal defects and lead to narrowed
airways and hypoplasia of the lungs. These branching
defects can be mimicked by inhibition of Rho kinase, a
known downstream effector of PCP and key regulator of the
cytoskeleton (12,44,45) and the branching defect can be par-
tially rescued in mutant lung explants by Rho stimulation.
We find that despite being competent to respond to FGF10 sig-
nalling, de novo bud formation is severely impaired in mutant
lung endoderm. Importantly, apical–basal polarity appears
largely unaffected in mutant lungs. Our studies demonstrate
that lung branching morphogenesis requires Celsr1 and
Vangl2 function, emphasizing a new role for these proteins
during development. Interestingly mutations in two other
PCP genes, Scribble and PTK7, also cause similar lung
defects (Yates et al. and Paudyal et al., manuscripts in prep-
aration). Ultimately, these mutant lung deficiencies are likely
to cause acute breathing difficulties (7) and almost certainly,
death, although this was not possible to demonstrate due to
neonatal death as a result of other tissue defects.
Although mutations in these genes do not prevent branching
morphogenesis completely, they do lead to a reduction in the
number of branches and major alterations to the shape of
branches that are able to form. This level of impact on
branch formation is consistent with that seen in mouse
mutants of other genes required for branching morphogenesis
(46–50). Our results in the early lung (lung explant and Celsr1
morpholino experiments) show an expansion in the size of the
bud, yet in the E14.5 and E18.5 lung, the airway lumen is con-
siderably narrowed. The lumen narrowing likely reflects the
disorganization of the airway epithelium and may also
suggest an inability to maintain the cytoskeletal integrity and
lumenal structure resulting in a collapse of the airway. The
airway narrowing also likely contributes to the reduction in
the size of the later embryonic lung.
Here we have shown that components of the PCP signalling
pathway play a critical role in lung epithelial tube formation.
The PCP signalling pathway regulates a number of different
types of cellular behaviours during development; it is currently
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unclear whether any of these are affected in lung development.
In vertebrates, PCP signalling regulates convergent extension
movements whereby intercalation of cells enables elongation
and narrowing of tissues, including rearrangement of the
neural plate during neurulation. Recent studies in the kidney
have shown that convergent extension occurs during kidney
tubule formation and that this process is mediated via the
PCP pathway (24). However, ex vivo culture of Celsr1 and
Vangl2 homozygous lungs reveals broader, but not shorter,
epithelial buds compared with wild-type. In addition, morpho-
lino knockdown experiments and time-lapse imaging revealed
the tissue is still able to elongate and extend to form ‘stalk’
regions, thereby suggesting the branching defects are not
caused by failure of tissue extension. This is not altogether
surprising given that elongation of the epithelial tubes is
much more modest in lung compared with that in kidney.
Other work in the kidney showed that disruption of PCP
leads to randomization of the orientation of cell division that
in turn causes dilation of tubules and formation of cysts, a
major cause of ciliary disease (51–53). It now appears that
both of these cellular behaviours are important in the kidney
and that tubule diameter is first established by convergent
extension during embryogenesis but is then maintained by
polarized cell divisions after birth (24). Other laboratories
have highlighted the role of the PCP signalling pathway for
proper morphogenesis of a tissue in a number of other distinct
sites including heart morphogenesis, formation of the female
reproductive tract and directed cell migration in vitro
(22,54–58). Future studies will be required to determine
whether any of these cellular behaviours are disrupted in
Celsr1Crsh and Vangl2Lp lungs.
The expression patterns of Celsr1 and Vangl2 suggest both
common and differential roles for these proteins in lung
branching morphogenesis
Most studies of PCP proteins emphasize their similar roles in
tissue development and frequently note their overlapping
expression patterns. In the lung, we observe asymmetric
enrichment of Celsr1 and Vangl2 towards or adjacent to the
lumen, respectively. Together with the absence or reduced
diameter of lumina observed in many Celsr1Crsh and
Vangl2Lp ‘airways’, this suggests that in common with other
apically enriched proteins, Celsr1 and Vangl2 may have an
important role in establishing a proper lumen i.e. they may
help to modulate co-ordinated cellular movement via regu-
lation of the cytoskeleton that is required for the formation
of a normal lumen. Interestingly, analysis of Vangl2
expression in Crsh mutants showed a distinct loss of Vangl2
enrichment adjacent to the lumen, suggesting that Celsr1 is
required to correctly localize Vangl2. We also noted that the
phenotype in Celsr1Crsh was consistently more severe than
that of Vangl2Lp. It is of note that Celsr1 has previously
been proposed to exist at the top of a hierarchy of PCP pro-
teins, helping to recruit other PCP proteins to the cell mem-
branes (55,56) and our data are consistent with this view.
In addition to some areas of overlapping expression, we
found intriguing differences in expression of Celsr1 and
Vangl2 that likely reflect some differing functions. Celsr1 is
highly expressed between buds as well as at sites where
bifurcation occurs and MO knockdown revealed that Celsr1
is indeed required for normal bud bifurcation. In contrast,
Vangl2 is not enriched at sites of tissue indentation or bifur-
cation and instead, the highest levels of Vangl2 are in cells
surrounding the lumen.
These differences in both protein localization and the phe-
notypes observed following Celsr1 MO knockdown indicate
that these proteins have distinct and independent functions
in some aspects of lung branching morphogenesis. Although
it is possible that these differences may be a consequence of
additional roles of these genes outside the PCP pathway, to
date, no such additional roles have been attributed to Vangl2
or Celsr1 making this possibility less likely. Using histology,
molecular markers and analysis of Celsr1 and Vangl2 mouse
mutants, we conclude that though both are obligatory for
normal lung development, these proteins regulate some dis-
tinct steps in airway formation.
Celsr1 is required for bud bifurcation
One mechanism of bud bifurcation previously proposed
involves newly synthesized extracellular matrix being depos-
ited transiently and focally in forming cleft regions (59,60).
At these points, the extracellular matrix is thought to act as
a ‘rock in the river’ by which the middle of the expanded
bud is constrained in position and the bud then bifurcates
and flows around this rock to form two new buds. Our data
on Celsr1 protein localization show that Celsr1 becomes loca-
lized to regions where bud growth is constrained, resembling a
‘rope’ which tethers the cells at the constriction point or
‘rock’. We therefore propose that Celsr1 is required for bud
bifurcation; this idea is supported by defects in bifurcation
that we observed following morpholino knockdown of
Celsr1. Studies of salivary gland branching suggests that
laminin may also be a component of the constriction point
and its expression shows an intriguing similarity to the
Celsr1 ‘rope’ that we observe in the lung endoderm cultures
(60). Celsr1 may play an active role in constraining the bifur-
cation event or may function as a scaffold protein to localize
other proteins to sites of constriction during branching. The
finding that Celsr1 is expressed in the basal lamina surround-
ing the lung epithelium is surprising, given that it is known as
a transmembrane protein: however, the protein contains a
number of laminin G repeats which may enable interaction
with the basement membrane. Finally, time-lapse imaging of
Celsr1 morpholino treated lung explants reveals reduced
branching and, in particular, inhibition of bud bifurcation pro-
viding further evidence that Celsr1 is required for bud bifur-
cation. These new data expand a molecular explanation for
the ‘rock in the river’ model as a mechanism to split the
expanded bud into two.
In conclusion, we show for the first time that PCP signalling
pathway components are required for normal lung branching
morphogenesis in vivo. On the basis of our analysis of
Celsr1Crsh and Vangl2Lp mutant mice demonstrating disrupted
lung development and cytoskeletal defects, as well as detailed
Celsr1 and Vangl2 protein localization data, we propose that
the PCP pathway is required for formation of normal epithelial
branches in the lung. In addition, our protein localization and
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morpholino knockdown data lead us to further propose that
Celsr1 is required for bud bifurcation.
We propose that in lung branching morphogenesis, com-
ponents of the PCP signalling pathway regulate morphogen-
etic movement of epithelial tissue, at least in part via Rho
kinase-mediated regulation of the cytoskeleton. The discovery
that Celsr1 and Vangl2 are required for lung epithelial tube
formation opens up a new avenue of research that will likely
increase our understanding of human diseases; particularly
those involving defects in lung architecture such as pulmonary
fibrosis. To this end, an important part of our future studies
will be to determine the roles of Celsr1 and Vangl2 in the post-
natal lung using conditional mouse mutants.
MATERIALS AND METHODS
Mouse strains and genotyping
Vangl2Lp mice (Murdoch et al., 27) were maintained on C3H/
HeH, Celsr1Crsh mice (26) were maintained on BALB/C or
C3H/HeH. Vangl2Lp homozygotes and heterozygotes were
identified by craniorachischisis and looped tail phenotypes,
respectively, littermates were used as controls. Crsh mice
and embryos were genotyped for the mutation itself by pyro-
sequencing, primer sequences available on request. Compari-
son of limb development in wild-type and homozygous
mutant embryos revealed no overall developmental delay.
Antibodies, immunostaining and immunoblotting
Four micrometre paraffin sections or 10 mm cryosections were
stained with haematoxylin and eosin or immunostained (61)
using antibodies to: Celsr1 1:1000, gift from C. Formstone,
manuscript in preparation (caroline.formstone@kcl.ac.uk);
Vangl2 1:500, gift from M. Montcouquiol; ZO-2 1:200,
PKCz 1:100, both Santa Cruz; rhodamine phalloidin 1:40 Invi-
trogen; pan-cytokeratin 1:500; non-muscle myosin IIA
1:1200; b-catenin 1:500; GM-130 1:1500, all Sigma;
pro-SP-C 1:1000; Laminin A chain 1:500, both Chemicon;
alpha smooth muscle actin 1:1000 Lab Vision; phos-
phoERK1/2 1:500 Biosource; phospho-histone H3 (pH3)
1:500 Upstate Cell Signaling; p44/42 MAP kinase 1:500,
Cell Signaling Technology. Incubations were overnight at
48C. Pre-incubation for 10 min with 2208C methanol was
carried out for phospho-ERK1/2. Antibodies were detected
with appropriate Alexa Fluor 488 or 594 secondary antibodies,
1:500 Invitrogen, or with ABC elite staining kit (Vector Labs).
Immunoblotting for ERK proteins was performed using
either 18 mg/lane of E12.5 wild-type and Vangl2Lp or 7 mg/
lane of E13.5 wild-type and Celsr1Crsh whole lung protein
extract with antibodies to total ERK (1:500), phosphoERK1/
2 (1:1000) and b-tubulin (1:5000). For PCP proteins, extract
from two morpholino-treated lung explants were loaded/lane
immunoblotted for b-actin (1:1000) or Celsr1 (1:3000).
Whole lung immunostaining
E12.5 and E14.5 wild-type and Celsr1Crsh/Crsh and Vangl2Lp/Lp
lungs were fixed in 4% paraformaldehyde (PFA) at 48C
for 1 h. Lungs were washed in PBT and blocked in 5%
FCS/PBS/0.1% Triton X-100 and incubated overnight at 48C
with either anti-Celsr1 1:1000 or anti-Vangl2 1:500 and
anti-Cytokeratin 1:500, before detection with an appropriate
secondary. Lungs were imaged using a Leica TCS SP5 confo-
cal.
Explant cultures
Left lung lobes were isolated from E11.5 mice (wild-type
tissue obtained from FVB/N, CD1 or C3H-HeH mice) and cul-
tured for 48 h in defined medium as described (61), or in 1:1
DMEM:F12 (Sigma) containing penicillin-streptomycin
(Sigma) and 0.01% bovine serum albumin (BSA, Sigma). In
some cases the media was supplemented with FGF10
(400 ng/ml, R&D systems), Rho kinase inhibitor Y27632
(37) (10–30 mM) or Rho kinase activator CNF-1 (20 ng/ml,
gift from K. Aktories and G. Schmidt). Following culture,
explants were fixed in 4% PFA, and photographed using a
Leica digital camera and imaging software. The number of
end buds at t ¼ 48 varies depending on the precise age of
the lung at explant and the strain of mice used. In all exper-
iments control and treated or wild-type and mutant lungs
were stage matched at the start of experiments. For explants
of lung endoderm, left lung lobes were removed from E11.5
mice and placed in 0.2% trypsin on ice for 45 min. Following
removal of the mesenchyme, explants were placed in growth
factor reduced matrigel (BD Biosciences) diluted 1:1 in
DMEM:F12 containing penicillin-streptomycin and 0.01%
BSA and cultured for up to 48 h in the same medium, in
some cases, media was supplemented with 400 ng/ml
FGF10. Photographs were taken at t ¼ 0, 24 and 48 h.
At 48 h, explants were fixed with 4% PFA, released from
Matrigel and the number of terminal buds counted.
Morpholino knock-down of Celsr1 function
Intact lungs from transgenic mice expressing GFP from the
beta-actin promoter (62) were dissected from E11.5 embryos
and cultured as described (Dean et al., 61). Specific morpho-
lino oligonucleotides (Gene Tools) against Celsr1 (AGCAC
AATCCATGCACCCGGCGCAC) or (TCCTGCCCACAGG
CCACTCACCTGA) or control (CCTCTTACCTCAGTTAC
AATTTATA) were added to the media at final concentration
of 15 mM at day zero (Dean et al., 61). Lung explants were
cultured for 48 h and then images taken every 4 min over a
period of 24 h on a Zeiss LSM 510 confocal microscope.
Statistical analysis
All statistics were computed using Excel and Graphpad soft-
ware. Fluorescent intensity analysis was performed on confo-
cal images using the LSM software. Error bars represent
standard error of mean and significance was scored using
unpaired two-tailed t-tests.
SUPPLEMENTARY MATERIAL
Supplementary Material is available at HMG online.
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